Detalhe da pesquisa
1.
Survival outcomes of alternate dosing schedule of pemetrexed as maintenance therapy in NSCLC: Single institution experience.
Lung Cancer
; 165: 49-53, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35085984
2.
Safety of Same-Day Vitamin B12 Supplementation in Patients Receiving Pemetrexed for the Treatment of Non-Small-Cell Lung Cancer or Pleural Mesothelioma: A Retrospective Analysis.
Clin Lung Cancer
; 19(6): 467-475, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30369425
3.
The pharmacokinetic and pharmacodynamic profile of tigecycline.
Clin Infect Dis
; 41 Suppl 5: S333-40, 2005 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16080071
4.
Pharmacokinetic/pharmacodynamic profile for tigecycline-a new glycylcycline antimicrobial agent.
Diagn Microbiol Infect Dis
; 52(3): 165-71, 2005 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16105560
5.
Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program.
Clin Infect Dis
; 36(2): 159-68, 2003 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12522747
6.
Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme.
Clin Pharmacokinet
; 42(15): 1411-23, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-14674791
7.
Successful treatment of methicillin-resistant Staphylococcus aureus pulmonary infection with linezolid in a patient with cystic fibrosis.
Pediatr Pulmonol
; 33(3): 221-3, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11836802
8.
Metformin and Not Diabetes Influences the Survival of Resected Early Stage NSCLC Patients.
J Cancer Sci Ther
; 6(7): 217-222, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26457130
9.
Exposure-response analyses of tigecycline tolerability in healthy subjects.
Diagn Microbiol Infect Dis
; 65(2): 123-9, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19748422
10.
Application of patient population-derived pharmacokinetic-pharmacodynamic relationships to tigecycline breakpoint determination for staphylococci and streptococci.
Diagn Microbiol Infect Dis
; 63(2): 155-9, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19150707
11.
Use of a clinically derived exposure-response relationship to evaluate potential tigecycline-Enterobacteriaceae susceptibility breakpoints.
Diagn Microbiol Infect Dis
; 63(1): 38-42, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19073300
12.
Crizotinib: a breakthrough for targeted therapies in lung cancer.
J Adv Pract Oncol
; 3(4): 267-72, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25031955
13.
Fluoroquinolone AUIC break points and the link to bacterial killing rates. Part 1: In vitro and animal models.
Ann Pharmacother
; 37(9): 1287-98, 2003 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12921513
14.
Fluoroquinolone AUIC break points and the link to bacterial killing rates. Part 2: human trials.
Ann Pharmacother
; 37(10): 1478-88, 2003 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-14519053
15.
Population pharmacokinetics of linezolid in patients treated in a compassionate-use program.
Antimicrob Agents Chemother
; 47(2): 548-53, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12543657
16.
Novel pharmacokinetic-pharmacodynamic model for prediction of outcomes with an extended-release formulation of ciprofloxacin.
Antimicrob Agents Chemother
; 48(6): 2061-8, 2004 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15155200